Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Thrombosis and Haemostasis
|
April 25, 1989
Immunogold electron-microscopic localization of calpain I in human erythrocytes
J A Samis, J S Elce
The Biochemical Journal
|
September 1, 1987
Calpain I remains intact and intracellular during platelet activation. Immunochemical measurements with monoclonal and polyclonal antibodies
J A Samis, G Zboril, J S Elce
Blood
|
August 8, 1998
Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function
J A Samis, E Kam, M E Nesheim, et al.
Biochimica Et Biophysica Acta
|
October 19, 1993
Molecular cloning and bacterial expression of cDNA for rat calpain II 80 kDa subunit
C I DeLuca, P L Davies, J A Samis, et al.
Blood
|
August 1, 1997
Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V
J A Samis, M Garrett, R P Manuel, et al.
Blood
|
January 29, 2000
Proteolytic processing of human coagulation factor IX by plasmin
J A Samis, G D Ramsey, J B Walker, et al.
The Biochemical Journal
|
June 1, 1991
Constitutive expression of calpain II in the rat uterus during pregnancy and involution
J A Samis, D W Back, E J Graham, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 31, 2004
Temporal changes in factors associated with neutrophil elastase and coagulation in intensive care patients with a biphasic waveform and disseminated intravascular coagulation
J A Samis, K A Stewart, C H Toh, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 20, 2004
Hemostatic and hematological abnormalities in gain-of-function fps/fes transgenic mice are associated with the angiogenic phenotype
W Sangrar, Y Senis, J A Samis, et al.
The Journal of Biological Chemistry
|
March 7, 1997
Functional characterization of recombinant human meizothrombin and Meizothrombin(desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition
H C Côté, L Bajzar, W K Stevens, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Thrombosis and Haemostasis
|
April 25, 1989
Immunogold electron-microscopic localization of calpain I in human erythrocytes
J A Samis, J S Elce
The Biochemical Journal
|
September 1, 1987
Calpain I remains intact and intracellular during platelet activation. Immunochemical measurements with monoclonal and polyclonal antibodies
J A Samis, G Zboril, J S Elce
Blood
|
August 8, 1998
Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function
J A Samis, E Kam, M E Nesheim, et al.
Biochimica Et Biophysica Acta
|
October 19, 1993
Molecular cloning and bacterial expression of cDNA for rat calpain II 80 kDa subunit
C I DeLuca, P L Davies, J A Samis, et al.
Blood
|
August 1, 1997
Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V
J A Samis, M Garrett, R P Manuel, et al.
Blood
|
January 29, 2000
Proteolytic processing of human coagulation factor IX by plasmin
J A Samis, G D Ramsey, J B Walker, et al.
The Biochemical Journal
|
June 1, 1991
Constitutive expression of calpain II in the rat uterus during pregnancy and involution
J A Samis, D W Back, E J Graham, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 31, 2004
Temporal changes in factors associated with neutrophil elastase and coagulation in intensive care patients with a biphasic waveform and disseminated intravascular coagulation
J A Samis, K A Stewart, C H Toh, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 20, 2004
Hemostatic and hematological abnormalities in gain-of-function fps/fes transgenic mice are associated with the angiogenic phenotype
W Sangrar, Y Senis, J A Samis, et al.
The Journal of Biological Chemistry
|
March 7, 1997
Functional characterization of recombinant human meizothrombin and Meizothrombin(desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition
H C Côté, L Bajzar, W K Stevens, et al.
Page
of 2